Literatur
-
1 WHO .The
world health report 1998. Life in the 21 st century - A vision
for all. 1998.
-
2
Kuhnl P, Seidl S, Stangel W. et al .
Antibody
to hepatitis C virus in German blood donors.
Lancet.
1989;
2
324
-
3
Heintges T, Mohr L, Niederau C.
Epidemiology
and clinical features of chronic viral hepatitis.
Dtsch
Med Wschr.
1994;
119
1365-1370
-
4
Heintges T, Wands J R.
Hepatitis C
virus: Epidemiology and transmission.
Hepatology.
1997;
26
521-526
-
5
Dienstag J L.
Sexual
and perinatal transmission of hepatitis C.
Hepatology.
1997;
26
66s-70s
-
6
Soto B, Rodrigo L, Garcia-Bengoechea M. et al .
Heterosexual
transmission of hepatitis C virus and the possible role of coexistent
human immunodeficiency virus infection in the index case. A multicentre
study of 423 pairings.
J Intern Med.
1994;
236
515-519
-
7
Gordon S C, Patel A H, Kulesza G W. et al .
Lack of evidence for the heterosexual transmission
of hepatitis C.
Am J Gastroenterol.
1992;
87
1849-1851
-
8
Wyld R, Robertson J R, Brettle R P. et al .
Absence
of hepatitis C virus transmission but frequent transmission of HIV-1
from sexual contact with doubly-infected individuals.
J
Infect.
1997;
35
163-166
-
9
Bresters D, Mauser-Bunschoten E P, Reesink H W. et al .
Sexual transmission of hepatitis C virus.
Lancet.
1993;
342
210-211
-
10
Conry-Cantilena C, VanRaden M, Gibble J. et al .
Routes of infection, viremia, and liver
disease in blood donors found to have hepatitis C virus infection.
N
Engl J Med.
1996;
334
1691-1696
-
11
Ohto H, Terazawa S, Sasaki N. et al .
Transmission
of hepatitis C virus from mothers to infants. The Vertical Transmission
of Hepatitis C Virus Collaborative Study Group.
N Engl
J Med.
1994;
330
744-750
-
12
Zanetti A R, Tanzi E, Romano L. et al .
Multicenter trial on mother-to-infant transmission
of GBV-C virus. The Lombardy Study Group on Vertical/Perinatal
Hepatitis Viruses Transmission.
J Med Virol.
1998;
54
107-112
-
13
Granovsky M O, Minkoff H L, Tess B H. et al .
Hepatitis C virus infection in the mothers
and infants cohort study.
Pediatrics.
1998;
102
355-359
-
14
Health NIo .
National
Institutes of Health Consensus Development Conference Panel statement:
Management of hepatitis C.
Hepatology.
1997;
26
2s-10s
-
15
EASL International Consensus
Conference on Hepatitis C .
Paris, 26-28, February
1999, Consensus Statement. European Association for the Study of
the Liver.
J Hepatol.
1999;
30
956-961
-
16
Puro V, Petrosillo N, Ippolito G.
Risk of hepatitis C
seroconversion after occupational exposures in health care workers.
Italian Study Group on Occupational Risk of HIV and Other Bloodborne
Infections.
Am J Infect Control.
1995;
23
273-277
-
17
Hasan F, Askar H, Al Khalidi J, Al Shamali M, Al Kalaoui M, Al Nakib B.
Lack
of transmission of hepatitis C virus following needlestick accidents.
Hepatogastroenterology.
1999;
46
1678-1681
-
18
Hamid S S, Farooqui B, Rizvi Q. et al .
Risk of transmission and features of hepatitis
C after needlestick injuries.
Infect Control Hosp Epidemiol.
1999;
20
63-64
-
19
Mizuno Y, Suzuki K, Mori M. et
al .
Study of needlestick accidents and hepatitis C
virus infection in healthcare workers by molecular evolutionary
analysis.
J Hosp Infect.
1997;
35
149-154
-
20
Mitsui T, Iwano K, Masuko K. et al .
Hepatitis C virus infection in medical
personnel after needlestick accident.
Hepatology.
1992;
16
1109-1114
-
21
Arai Y, Noda K, Enomoto N. et al .
A prospective
study of hepatitis C virus infection after needlestick accidents.
Liver.
1996;
16
331-334
-
22
Pawlotsky J M, Ben Yahia M, Andre C. et al .
Immunological disorders in C virus chronic
active hepatitis: A prospective case-control study.
Hepatology.
1994;
19
841-848
-
23
Agnello V, Chung R T, Kaplan L M.
A
role for hepatitis C virus infection in type II cryoglobulinemia.
N
Engl J Med.
1992;
327
1490-1495
-
24
Lamprecht P, Schnabel A, Gross W L.
Hepatitis
C virus-associated cryoglobulinemic vasculitis. Physiopathology,
diagnosis and therapy.
Dtsch Med Wschr.
1998;
123
637-642
-
25
Ferri C, Caracciolo F, Zignego A L. et al .
Hepatitis
C virus infection in patients with non-Hodgkin"s lymphoma.
Br
J Haematol.
1994;
88
392-394
-
26
Mazzaro C, Zagonel V, Monfardini S. et al .
Hepatitis C virus and non-Hodgkin"s
lymphomas.
Br J Haematol.
1996;
94
544-550
-
27
Neumann A U, Lam N P, Dahari H. et al .
Hepatitis C viral dynamics in vivo and
the antiviral efficacy of interferon-alpha therapy.
Science.
1998;
282
103-107
-
28
Tsai S L, Chen Y M, Chen M H. et al .
Hepatitis C virus variants circumventing
cytotoxic T lymphocyte activity as a mechanism of chronicity.
Gastroenterology.
1998;
115
954-965
-
29
Rehermann B, Chang K M, McHutchinson J. et al .
Differential cytotoxic T-lymphocyte responsiveness
to the hepatitis B and C viruses in chronically infected patients.
J
Virol.
1996;
70
7092-7102
-
30
Lechmann M, Ihlenfeldt H G, Braunschweiger I. et al .
T- and B-cell responses to different hepatitis
C virus antigens in patients with chronic hepatitis C infection
and in healthy anti-hepatitis C virus - positive blood
donors without viremia.
Hepatology.
1996;
24
790-795
-
31
Botarelli P, Brunetto M R, Minutello M A. et al .
T-lymphocyte response to hepatitis C virus
in different clinical courses of infection.
Gastroenterology.
1993;
104
580-587
-
32
Poynard T, Bedossa P, Opolon P.
Natural
history of liver fibrosis progression in patients with chronic hepatitis
C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
Lancet.
1997;
349
825-832
-
33
Kenny-Walsh E.
Clinical
outcomes after hepatitis C infection from contaminated anti-D immune
globulin. Irish Hepatology Research Group.
N Engl J
Med.
1999;
340
1228-1233
-
34
Serfaty L, Aumaitre H, Chazouilleres O. et al .
Determinants of outcome of compensated
hepatitis C virus-related cirrhosis.
Hepatology.
1998;
27
1435-1440
-
35
Tong M J, el Farra N S, Reikes A R, Co R L.
Clinical outcomes
after transfusion-associated hepatitis C.
N Engl J Med.
1995;
332
1463-1466
-
36
El-Serag H B, Mason A C.
Rising incidence
of hepatocellular carcinoma in the United States.
N Engl
J Med.
1999;
340
745-750
-
37
Shakil A O, Conry-Cantilena C, Alter H J. et al .
Volunteer blood donors with antibody to
hepatitis C virus: Clinical, biochemical, virologic, and histologic
features. The Hepatitis C Study Group.
Ann Intern Med.
1995;
123
330-337
-
38
Naito M, Hayashi N, Hagiwara H. et al .
Serum
hepatitis C virus RNA quantity and histological features of hepatitis
C virus carriers with persistently normal ALT levels.
Hepatology.
1994;
19
871-875
-
39
Alberti A, Morsica G, Chemello L. et al .
Hepatitis C viraemia and liver disease
in symptom-free individuals with anti-HCV.
Lancet.
1992;
340
697-698
-
40
Sangiovanni A, Morales R, Spinzi G. et al .
Interferon alfa treatment of HCV RNA carriers
with persistently normal transaminase levels: A pilot randomized
controlled study.
Hepatology. .
1998;
27
853-856
-
41
Pawlotsky J M, Lonjon I, Hezode C. et al .
What strategy should be used for diagnosis
of hepatitis C virus infection in clinical laboratories?.
Hepatology.
1998;
27
1700-1702
-
42
Roggendorf M, Lu M, Meisel H, Riffelmann M, Schreier E, Viazov S.
Rational
use of diagnostic tools in hepatitis C.
J Hepatol.
1996;
24
26-34
-
43
Long G S, Bacon B R, Bisceglie A M.
Interpreting
serologic tests for hepatitis C virus infection: Balancing cost
and clarity.
Cleve Clin J Med.
1996;
63
264268
-
44
Damen M, Cuypers H T, Zaaijer H L. et al .
International
collaborative study on the second EUROHEP HCV-RNA reference panel.
J
Virol Methods.
1996;
58
175-185
-
45
Lok A S, Gunaratnam N T.
Diagnosis
of hepatitis C.
Hepatology.
1997;
26
48S-56S
-
46
Roth W K, Lee J H, Ruster B, Zeuzem S.
Comparison of two quantitative
hepatitis C virus reverse transcriptase PCR assays.
J
Clin Microbiol.
1996;
34
261-264
-
47
Pawlotsky J M, Martinot-Peignoux M, Poveda J D. et al .
Quantification of hepatitis C virus RNA
in serum by branched DNA-based signal amplification assays.
J
Virol Methods.
1999;
79
227-235
-
48
Takeuchi T, Katsume A, Tanaka T. et al .
Real-time detection system for quantification
of hepatitis C virus genome.
Gastroenterology.
1999;
116
636-642
-
49
Kawai S, Yokosuka O, Kanda T, Imazeki F, Maru Y, Saisho H.
Quantification
of hepatitis C virus by TaqMan PCR: Comparison with HCV Amplicor
Monitor assay.
J Med Virol.
1999;
58
121-126
-
50
Huber K R, Sebesta C, Bauer K.
Detection
of common hepatitis C virus subtypes with a third-generation enzyme
immunoassay.
Hepatology.
1996;
24
471-473
-
51
Fischer H P, Willsch E, Bierhoff E, Pfeifer U.
Histopathologic findings
in chronic hepatitis C.
J Hepatol.
1996;
24
35-42
-
52
Bukh J, Miller R H, Purcell R H.
Genetic heterogeneity
of hepatitis C virus: Quasispecies and genotypes.
Semin
Liver Dis.
1995;
15
41-63
-
53
Simmonds P, Alberti A, Alter H J. et al .
A proposed system for the nomenclature
of hepatitis C viral genotypes.
Hepatology.
1994;
19
1321-1324
Korrespondenz
Dr. med. Ludger Leifeld
Medizinische Universitäts-Klinik und Poliklinik
I
Allgemeine Innere Medizin
Rheinische Friedrich-Wilhelms-Universität Bonn
Sigmund-Freud-Straße 25
53105 Bonn
Phone: 0228/287-5383
Fax: 0228/287-4323
Email: l.leifeld@uni-bonn.de
